Total Funding
49
56
Total FundingPost-IPO Debt raised
Growth Score
-18 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
72888
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class
William Rice: President & Chief Executive OfficerPast Role: Achillion Pharmaceuticals, Founder, President, CEO, Director
Fletcher Payne: Senior Vice President, Chief Business Officer & Chief Financial OfficerPast Role: Aptose Biosciences, Senior Vice President & Chief Financial Officer
About the Company
Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to
clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.
